← Back to patent-cliff list
CAS 1478365-70-6
tert-butyl (4-bromopyrimidin-2-yl)carbamate
Codes：RILP-015
Application context (from source-drug indications)
HIV感染盐酸利匹韦林肝功能衰退盐酸利匹韦林获得性免疫缺损综合征盐酸利匹韦林避孕行为盐酸利匹韦林
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸利匹韦林Rilpivirine Hydrochloride | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-bromo-2,6-dimethylaniline→4-bromopyrimidin-2-amine→tert-butyl (4-bromopyrimidin-2-yl)carbamate→tert-butyl (4-((4-bromo-2-methylphenyl)amino)pyrimidin-2-yl)carbamate→N4-(4-bromo-2,6-dimethylphenyl)pyrimidine-2,4-diamine→(E)-3-(4-((2-aminopyrimidin-4-yl)amino)-3,5-dimethylphenyl)acrylonitrile→4-bromobenzonitrile
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.